<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    <meta name="keywords" content="Hexo Theme Keep">
    <meta name="description" content="Hexo Theme Keep">
    <meta name="author" content="肿瘤界">
    
    <title>
        
            ASCO23特别篇之研究物语：HERIZON-BTC-01研究--O医生投稿 |
        
        肿瘤界比赛/投稿公示平台
    </title>
    
<link rel="stylesheet" href="/zlj_submit/css/style.css">

    <link rel="shortcut icon" href="/zlj_submit/images/logo.svg">
    
<link rel="stylesheet" href="/zlj_submit/font/css/fontawesome.min.css">

    
<link rel="stylesheet" href="/zlj_submit/font/css/regular.min.css">

    
<link rel="stylesheet" href="/zlj_submit/font/css/solid.min.css">

    
<link rel="stylesheet" href="/zlj_submit/font/css/brands.min.css">

    <script id="hexo-configurations">
    let KEEP = window.KEEP || {}
    KEEP.hexo_config = {"hostname":"cardioio.github.io","root":"/zlj_submit/","language":"en","path":"search.json"}
    KEEP.theme_config = {"toc":{"enable":false,"number":false,"expand_all":false,"init_open":false},"style":{"primary_color":"#0066cc","logo":"/images/logo.svg","favicon":"/images/logo.svg","avatar":"/images/avatar.svg","font_size":null,"font_family":null,"hover":{"shadow":false,"scale":false},"first_screen":{"enable":true,"header_transparent":false,"background_img":"/images/bg.svg","description":"让您的学术观点在肿瘤学知识的海洋中发光.","font_color":null,"hitokoto":false},"scroll":{"progress_bar":false,"percent":false}},"local_search":{"enable":true,"preload":true},"code_copy":{},"code_block":{"tools":{"enable":false,"style":"default"},"highlight_theme":"default"},"side_tools":{},"pjax":{"enable":false},"lazyload":{"enable":false},"comment":{"enable":false,"use":"valine","valine":{"appid":null,"appkey":null,"server_urls":null,"placeholder":null},"gitalk":{"github_id":null,"github_admins":null,"repository":null,"client_id":null,"client_secret":null,"proxy":null},"twikoo":{"env_id":null,"region":null,"version":"1.6.8"},"waline":{"server_url":null,"reaction":false,"version":2}},"post":{"author_label":{"enable":true,"auto":false,"custom_label_list":["医生"]},"word_count":{"enable":true,"wordcount":true,"min2read":true},"img_align":"center","copyright_info":true},"version":"3.6.1"}
    KEEP.language_ago = {"second":"%s seconds ago","minute":"%s minutes ago","hour":"%s hours ago","day":"%s days ago","week":"%s weeks ago","month":"%s months ago","year":"%s years ago"}
    KEEP.language_code_block = {"copy":"Copy code","copied":"Copied","fold":"Fold code block","folded":"Folded"}
    KEEP.language_copy_copyright = {"copy":"Copy copyright info","copied":"Copied","title":"Original article title","author":"Original article author","link":"Original article link"}
  </script>
<meta name="generator" content="Hexo 6.3.0"></head>


<body>
<div class="progress-bar-container">
    

    
</div>


<main class="page-container">

    

    <div class="page-main-content">

        <div class="page-main-content-top">
            
<header class="header-wrapper">

    <div class="header-content">
        <div class="left">
            
                <a class="logo-image" href="/">
                    <img src="/zlj_submit/images/logo.svg">
                </a>
            
            <a class="logo-title" href="/">
               肿瘤界比赛/投稿公示平台
            </a>
        </div>

        <div class="right">
            <div class="pc">
                <ul class="menu-list">
                    
                        <li class="menu-item">
                            <a class=""
                               href="/zlj_submit/"
                            >
                                主页
                            </a>
                        </li>
                    
                        <li class="menu-item">
                            <a class=""
                               href="/zlj_submit/archives"
                            >
                                投稿归档
                            </a>
                        </li>
                    
                    
                        <li class="menu-item search search-popup-trigger">
                            <i class="fas fa-search"></i>
                        </li>
                    
                </ul>
            </div>
            <div class="mobile">
                
                    <div class="icon-item search search-popup-trigger"><i class="fas fa-search"></i></div>
                
                <div class="icon-item menu-bar">
                    <div class="menu-bar-middle"></div>
                </div>
            </div>
        </div>
    </div>

    <div class="header-drawer">
        <ul class="drawer-menu-list">
            
                <li class="drawer-menu-item flex-center">
                    <a class=""
                       href="/zlj_submit/">主页</a>
                </li>
            
                <li class="drawer-menu-item flex-center">
                    <a class=""
                       href="/zlj_submit/archives">投稿归档</a>
                </li>
            
        </ul>
    </div>

    <div class="window-mask"></div>

</header>


        </div>

        <div class="page-main-content-middle">

            <div class="main-content">

                
                    <div class="fade-in-down-animation">
    <div class="post-page-container">
        <div class="article-content-container">

            <div class="article-title">
                <span class="title-hover-animation">ASCO23特别篇之研究物语：HERIZON-BTC-01研究--O医生投稿</span>
            </div>

            
                <div class="article-header">
                    <div class="avatar">
                        <img src="/zlj_submit/images/avatar.svg">
                    </div>
                    <div class="info">
                        <div class="author">
                            <span class="name">肿瘤界</span>
                            
                                <span class="author-label">医生</span>
                            
                        </div>
                        <div class="meta-info">
                            
<div class="article-meta-info">
    <span class="article-date article-meta-item">
        
            <i class="fa-regular fa-calendar-plus"></i>&nbsp;
        
        <span class="pc">2023-07-17 10:13:28</span>
        <span class="mobile">2023-07-17 10:13</span>
    </span>
    
        <span class="article-update-date article-meta-item">
        <i class="fas fa-file-pen"></i>&nbsp;
        <span class="pc">2023-07-17 10:13:28</span>
    </span>
    
    
    

    
    
        <span class="article-wordcount article-meta-item">
            <i class="fas fa-file-word"></i>&nbsp;<span>1.2k Words</span>
        </span>
    
    
        <span class="article-min2read article-meta-item">
            <i class="fas fa-clock"></i>&nbsp;<span>4 Mins</span>
        </span>
    
    
</div>

                        </div>
                    </div>
                </div>
            

            <div class="article-content keep-markdown-body">
                

                <p><strong>这届ASCO对HER2还真是偏爱啊。</strong><br>除了昨天我们说的双HER2靶向 #PHERGain 研究，实际上ASCO还曝光了HERIZON-BTC-01研究，使用的是一种名为<a class="link"   target="_blank" rel="noopener" href="https://www.cancer123.com/drugs/494/" >泽尼达妥单抗（Zanidatamab）<i class="fas fa-external-link-alt"></i></a>，代号ZW25的新药。它是能够结合HER2两个位点的靶向药物，实现了双靶一抗效果的同时，并在有HER2扩增的胆道癌后线治疗开花结果，取得了客观反应率41.3％的好成绩。<br>胆道癌虽然发病率不高，但大多数患者发现时就已经在晚期了，局部胆道癌的5年生存率不足20%，而远处转移的患者生存率仅3%，目前主要还是以基于铂类的化疗为主。<br>据统计，<a class="link"   target="_blank" rel="noopener" href="https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00242-5/fulltext" >大约20-30%的胆囊癌、20％的肝外胆管癌和4％-5％的肝内胆管癌中，会有HER2的突变、扩增或过度表达<i class="fas fa-external-link-alt"></i></a>。有些小样本临床研究已经初步证实，胆道癌患者使用靶向HER2治疗可以有一定的临床获益。</p>
<h5 id="此次ASCO年会上公布的HERIZON-BTC-01研究让我最感兴趣的是，ZW25这个新药是如何实现单抗双靶的？"><a href="#此次ASCO年会上公布的HERIZON-BTC-01研究让我最感兴趣的是，ZW25这个新药是如何实现单抗双靶的？" class="headerlink" title="此次ASCO年会上公布的HERIZON-BTC-01研究让我最感兴趣的是，ZW25这个新药是如何实现单抗双靶的？"></a>此次ASCO年会上公布的HERIZON-BTC-01研究让我最感兴趣的是，ZW25这个新药是如何实现单抗双靶的？</h5><p>ZW25可以与HER2蛋白这个跨膜蛋白的两个位置结合，一个是HER2形成二聚体的地方，另一个是细胞外靠近细胞膜的地方。这种双结合位使得ZW25像一个发卡，把HER2卡在细胞膜上，形成ZW25-HER2组合，然后触发细胞把这兄弟俩内吞到细胞内，最终让HER2下调。这个独特的双靶设计已经在1期临床时被证实，优于昨天我们说的曲妥珠单抗+帕妥珠单抗的组合对HER2的调控作用。<br>ZW25已经被百济神州引进，目前已处于III期临床阶段，我国的胆道癌患者应该在不久的将来就可以用上了。</p>
<h5 id="接下来我们言归正传，HERIZON-BTC-01研究是怎么做的？"><a href="#接下来我们言归正传，HERIZON-BTC-01研究是怎么做的？" class="headerlink" title="接下来我们言归正传，HERIZON-BTC-01研究是怎么做的？"></a>接下来我们言归正传，HERIZON-BTC-01研究是怎么做的？</h5><p>这是一项全球多中心、2b 期、单臂研究，入组的是有HER2扩增的胆道癌患者。<a class="link"   target="_blank" rel="noopener" href="http://whyes.org/2023/asco-2023" >复旦大学附属中山医院也是共同的牵头单位之一<i class="fas fa-external-link-alt"></i></a>。研究原文已经同期<a class="link"   target="_blank" rel="noopener" href="https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00242-5/fulltext" >发表在 Lancet Oncology 杂志上<i class="fas fa-external-link-alt"></i></a>。<br>由于只是2b期的研究，所以只入组了 87 例患者；研究者通过原位杂交确认是否有HER2扩增，PS评分为0或1。根据HER2免疫组化评分，也就是HER2表达的多少，将患者分配到HER2表达 2+或3+以及0或1+两个队列，分别编号队列1和队列2。<br>在 HER2高表达（2+&#x2F;3+）的队列中，也就是队列 1 共 80 例，其中 51% 是胆囊癌，29% 肝内胆管癌，20% 肝外胆管癌。HERIZON-BTC-01 研究主要观察的是队列1 中患者的疗效和安全性数据，即将主要终点设置为队列1经过ZW25治疗后的的客观反应率（ORR）。ZW25的使用方法是每两周静脉注射，剂量为每kg体重20mg。即便队列1最终只纳入了80例，但HERIZON-BTC-01研究仍是迄今为止报道的HER2扩增的胆道癌中规模最大的临床试验。<br>结果发现，队列1中68.4% 的患者出现了不同程度的肿瘤缩小，中位PFS为5.5个月。<br><img src="https://p.ipic.vip/5o8b58.png#id=bjFbD&originHeight=383&originWidth=680&originalType=binary&ratio=1&rotation=0&showTitle=false&status=done&style=none&title="><br><img src="https://p.ipic.vip/sigbcv.png#height=386&id=Qljbw&originHeight=634&originWidth=1114&originalType=binary&ratio=1&rotation=0&showTitle=false&status=done&style=none&title=&width=679"><br>在中位随访 12.4 月后，经影像评估的客观缓解率（ORR ）为41.3%，中位缓解持续时间（DoR）为12.9 月。<br>ZW25的安全性数据表现同样不错，主要的治疗相关不良反应是腹泻（5%）。没有4级治疗相关不良事件，也没有治疗相关死亡。<br>上述这些结果支持一抗双HER2靶点的ZW25作为未来HER2阳性的晚期胆道癌潜在用药，并作为一线化疗的联合治疗。</p>
<h6 id="最后谈谈我的一点想法。"><a href="#最后谈谈我的一点想法。" class="headerlink" title="最后谈谈我的一点想法。"></a>最后谈谈我的一点想法。</h6><p>由于胆管&#x2F;胆道肿瘤侵袭程度高，跟胰腺癌比较相似，对化疗&#x2F;免疫治疗的反应相对比较低，一直缺少有效的治疗手段。在HERIZON-BTC-01之前，就有学者对HER2扩增胆道癌做了曲妥珠单抗加帕妥珠单抗的双靶治疗的初步探索（<a class="link"   target="_blank" rel="noopener" href="https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00336-3/fulltext" >MyPathway研究<i class="fas fa-external-link-alt"></i></a>），结果表明39例受试者中只有9例达到部分缓解，也就是客观缓解率为23%。而本次HERIZON-BTC-01的缓解率达到了40%以上，说明ZW25确实是在HER2阻断上有过人之处，只要上市就能跻身HER2阳性的胆道癌后线治疗的前列。<br>感谢复旦大学附属中山医院的@whyes医生对本次节目的大力支持，请大家关注他的公众号《肿瘤学快讯》和<a class="link"   target="_blank" rel="noopener" href="https://whyes.org/" >博客<i class="fas fa-external-link-alt"></i></a>，了解更多肝癌领域的研究进展。</p>

            </div>

            
                <div class="post-copyright-info">
                    
<div class="article-copyright-info-container">
    <ul class="copyright-info-content">
        <li class="post-title">
            <span class="type">Post title</span>: <span class="content">ASCO23特别篇之研究物语：HERIZON-BTC-01研究--O医生投稿</span>
        </li>
        <li class="post-author">
            <span class="type">Post author</span>: <span class="content">肿瘤界</span>
        </li>
        <li class="post-time">
            <span class="type">Create time</span>: <span class="content">2023-07-17 10:13:28</span>
        </li>
        <li class="post-link">
            <span class="type">Post link</span>: <span class="content">2023/07/17/ASCO23特别篇之研究物语：HERIZON-BTC-01研究--O医生投稿/</span>
        </li>
        <li class="post-license">
            <span class="type">Copyright notice</span>: <span class="content">All articles in this blog are licensed under <a class="license" target="_blank" rel="noopener" href="https://creativecommons.org/licenses/by-nc-sa/4.0/deed.zh">BY-NC-SA</a> unless stating additionally.</span>
        </li>
    </ul>
    <div class="copy-copyright-info flex-center tooltip" data-content="Copy copyright info" data-offset-y="-2px">
        <i class="fa-solid fa-copy"></i>
    </div>
</div>

                </div>
            

            

            
                <div class="article-nav">
                    
                        <div class="article-prev">
                            <a class="prev"
                               rel="prev"
                               href="/zlj_submit/2023/07/17/ASCO23%E7%89%B9%E5%88%AB%E7%AF%87%E4%B9%8B%E7%A0%94%E7%A9%B6%E7%89%A9%E8%AF%AD%EF%BC%9APHERGain%E7%A0%94%E7%A9%B6--Y%E5%8C%BB%E7%94%9F%E6%8A%95%E7%A8%BF/"
                            >
                            <span class="left arrow-icon flex-center">
                              <i class="fas fa-chevron-left"></i>
                            </span>
                                <span class="title flex-center">
                                <span class="post-nav-title-item">ASCO23特别篇之研究物语：PHERGain研究--Y医生投稿</span>
                                <span class="post-nav-item">Prev posts</span>
                            </span>
                            </a>
                        </div>
                    
                    
                        <div class="article-next">
                            <a class="next"
                               rel="next"
                               href="/zlj_submit/2023/07/17/ASCO23%E7%89%B9%E5%88%AB%E7%AF%87%E4%B9%8B%E7%A0%94%E7%A9%B6%E7%89%A9%E8%AF%AD%EF%BC%9A%20DUO-O%E7%A0%94%E7%A9%B6--D%E5%8C%BB%E7%94%9F%E6%8A%95%E7%A8%BF/"
                            >
                            <span class="title flex-center">
                                <span class="post-nav-title-item">ASCO23特别篇之研究物语： DUO-O研究--D医生投稿</span>
                                <span class="post-nav-item">Next posts</span>
                            </span>
                                <span class="right arrow-icon flex-center">
                              <i class="fas fa-chevron-right"></i>
                            </span>
                            </a>
                        </div>
                    
                </div>
            

            
        </div>

        
    </div>
</div>


                
            </div>

        </div>

        <div class="page-main-content-bottom">
            
<footer class="footer">
    <div class="info-container">
        <div class="copyright-info info-item">
            &copy;
            
                <span>2020</span> -
            
            2023
            
                &nbsp;<i class="fas fa-heart icon-animate"></i>
                &nbsp;<a href="/">肿瘤界</a>
            
        </div>
        
        <div class="theme-info info-item">
            Powered by <a target="_blank" href="https://hexo.io">Hexo</a>&nbsp;|&nbsp;Theme&nbsp;<a class="theme-version" target="_blank" href="https://github.com/XPoet/hexo-theme-keep">Keep v3.6.1</a>
        </div>
        
        
    </div>
</footer>

        </div>
    </div>

    
        <div class="post-tools">
            <div class="post-tools-container">
    <ul class="tools-list">
        <!-- TOC aside toggle -->
        

        <!-- go comment -->
        
    </ul>
</div>

        </div>
    

    <div class="right-bottom-side-tools">
        <div class="side-tools-container">
    <ul class="side-tools-list">
        <li class="tools-item tool-font-adjust-plus flex-center">
            <i class="fas fa-search-plus"></i>
        </li>

        <li class="tools-item tool-font-adjust-minus flex-center">
            <i class="fas fa-search-minus"></i>
        </li>

        <li class="tools-item tool-dark-light-toggle flex-center">
            <i class="fas fa-moon"></i>
        </li>

        <!-- rss -->
        

        
            <li class="tools-item tool-scroll-to-top flex-center">
                <i class="fas fa-arrow-up"></i>
            </li>
        

        <li class="tools-item tool-scroll-to-bottom flex-center">
            <i class="fas fa-arrow-down"></i>
        </li>
    </ul>

    <ul class="exposed-tools-list">
        <li class="tools-item tool-toggle-show flex-center">
            <i class="fas fa-cog fa-spin"></i>
        </li>
        
    </ul>
</div>

    </div>

    <div class="zoom-in-image-mask">
    <img class="zoom-in-image">
</div>


    
        <div class="search-pop-overlay">
    <div class="popup search-popup">
        <div class="search-header">
          <span class="search-input-field-pre">
            <i class="fas fa-keyboard"></i>
          </span>
            <div class="search-input-container">
                <input autocomplete="off"
                       autocorrect="off"
                       autocapitalize="off"
                       placeholder="Search..."
                       spellcheck="false"
                       type="search"
                       class="search-input"
                >
            </div>
            <span class="close-popup-btn">
                <i class="fas fa-times"></i>
            </span>
        </div>
        <div id="search-result">
            <div id="no-result">
                <i class="fas fa-spinner fa-pulse fa-5x fa-fw"></i>
            </div>
        </div>
    </div>
</div>

    

</main>




<script src="/zlj_submit/js/utils.js"></script>

<script src="/zlj_submit/js/main.js"></script>

<script src="/zlj_submit/js/header-shrink.js"></script>

<script src="/zlj_submit/js/back2top.js"></script>

<script src="/zlj_submit/js/dark-light-toggle.js"></script>





    
<script src="/zlj_submit/js/local-search.js"></script>







<div class="post-scripts">
    
        
<script src="/zlj_submit/js/post-helper.js"></script>

        
        
    
</div>



</body>
</html>
